Outdoor public places smoke-free in Sweden
The Swedish government banned smoking in outdoor public places from July 1st. The following places should now be smoke-free: entrances to public buildings,...
Survey on the use of lay language summaries in paediatric clinical trials
The European Forum of Good Clinical Practices (EFGCP) in collaboration with the European Federation of Pharmaceutical Industries and Association (EFPIA)...
EFA Statement of Condolence on the Death of Hubert Nettel, EFA Board Member and Treasurer
Sep 24, 2019
Brussels, Belgium (September 24, 2019) – Mikaela Odemyr, president of the European Federation ofAllergy and Airways Diseases Patients’...
EFA launches European report "Active Patients Access Care"
EFA eagerly launches its new European report “Active Asthma and COPD Patients ACCESS Care”. The report unveils new patient evidence on asthma and COPD patients’ access to diagnosis and care, involvement in the care they receive through empowerment and prevention.
EFA signs joint letter to Politico after promotion of Tobacco Industry
EFA has signed a joint open letter to politico.eu, a Brussels based online magazine covering European politics, policy and governmental affairs. The magazine...
Join us on the 2nd World Atopic Eczema Day on September 14th
On September 14th, EFA, together with Global Skin, is marking World Atopic Eczema Day. With the day’s theme BENEATH THE SURFACE we raise awareness and...
EFA at the Patient Access Partnership conference on the Future of Health
On 11 and 12 July, EFA was proud to contribute to the high-level conference of Patient Access Partnership (PACT) on ‘The Future of Health: Advancing...
Save the Date: World Atopic Eczema Day 14th September
On September 14th, EFA together with Global Skin we are marking the 2nd World Atopic Eczema Day with the theme BENEATH THE SURFACE to raise awareness and...
EFA response to EMA consultation on allergen product development in low-sized populations
The European Medicines Agency (EMA) launched a public consultation on the basis of a concept paper for a ‘Guideline for allergen products development...
EFA Response to EMA Public Consultation on Patient Registries
The European Medicines Agency (EMA) launched a public consultation on the basis of a discussion paper focusing on the “use of patient disease registries...
EFA response to WHO invitation for public comment: Global Action Plan for Healthy Lives and Well-being
EFA provided input in the call for comments organised by the World Health Organisation (WHO), regarding strengthening collaboration among multilateral...
Medical Devices Regulation - Guidance on graphical symbols
The Medical Devices Regulation (2017/745 EU) entered into force in 2017 with rules being applicable after a transitional period ending in spring 2020....
EFSA publishes guidance on the use of threshold of toxicological concern approach in food safety assessment
The European Food Safety Authority (EFSA) carried out a public consultation to receive input from the scientific community and all interested parties on...
EFA at EFPIA Annual Conference
EFA Director Susanna Palkonen attended the annual networking event of the European Federation of Pharmaceutical Industries Associations (EFPIA). The event...
Medicines for rare diseases and children conference
On June 17th, the European Commission Directorate General for Health and Food Safety (DG SANTE) organised a conference on medicines for rare diseases and...
EFA in the EU Chemicals Policy 2030 conference
EFA was present in the conference on EU chemicals policy 2030, organised by the European Chemicals Agency (ECHA) in Brussels on 27-28 June. On the 1st...
EPSCO Council adopts tougher rules for Persistent Organic Pollutants (POPs)
On 13th June, the Council adopted stricter rules on the so-called Persistent Organic Pollutants (POPs), a list of chemical substances which are dangerous...
United Nations: Tobacco Control as Human Rights and Ministerial meeting on sustainable development
In light of the 41st session of the United Nations (UN) Human Rights Council which took place from June 14th to July 12th in Geneva, Switzerland, the Secretariat...
MyAirCoach presented at key medicines conference
On Friday 14th June, EFA was invited to speak at the Annual Medicines Europe and International Generic and Biosimilar Medicines Association Conference...
EFA meets patient group in Georgia
During the last five years, the EFA Capacity Building project has provided our members with tools to fill gaps in recognition and funding, but also helped...